These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1703859)

  • 1. [Plasmapheresis and/or intermediate high dosage immunoglobulin therapy--effective measures in threatened premature labor and intrauterine hemolysis in anti-PP1Pk (-Tja)?].
    Heim MU; Weidemann R; Brehm G; Versmold H; Mempel W
    Beitr Infusionsther; 1990; 26():302-6. PubMed ID: 1703859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pregnancy with an extremely rare P blood group with anti-PP1Pk].
    Strowitzki T; Wiedemann R; Heim MU; Brehm G; Roithmeier A
    Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):710-3. PubMed ID: 1743470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-Tja (PP1Pk) isoimmunization. A case, a review of the literature].
    Haentjens-Verbeke K; Dufour P; Vinatier D; Bernardi C; Fonteyne G; Monnier JC; Mannessier L
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):393-7. PubMed ID: 8360439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis for the treatment of repeated early pregnancy wastage associated with anti-P.
    Rock JA; Shirey RS; Braine HG; Ness PM; Kickler TS; Niebyl JR
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):57S-60S. PubMed ID: 4022518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients.
    Fernández-Jiménez MC; Jiménez-Marco MT; Hernández D; González A; Omeñaca F; de la Cámara C
    Vox Sang; 2001 Feb; 80(2):117-20. PubMed ID: 11348543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of plasmapheresis in pregnancy with antenatal prediction of a serious hemolytic disease due to Rh immunization.
    Woytoń J; Partyka T; Gajewska E; Kwoczyńska K; Baranowski H; Narczewska B; Bochenek S; Zukowska B; Róg-Malinowski M; Dzierzkowa-Borodej W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1139-46. PubMed ID: 107917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of fetal hemolytic disease using plasmapheresis].
    Schwarzlos G; During R; Müller S; Stark KH; Plesse R
    Zentralbl Gynakol; 1989; 111(24):1599-603. PubMed ID: 2624011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing a pregnancy in the presence of the rare blood group antibody PP1Pk.
    Conlan S
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):479-80. PubMed ID: 15387880
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages.
    Hanafusa N; Noiri E; Yamashita T; Kondo Y; Suzuki M; Watanabe Y; Kanai T; Miyashita E; Tsuno NH; Fujii T; Kozuma S; Takahashi K; Taketani Y; Nakao A; Fujita T
    Ther Apher Dial; 2006 Dec; 10(6):498-503. PubMed ID: 17199881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary management of anti-PP1P
    Lépine MS; Goua V; Debouverie OS; Giraud C; Rafat C; Thonier V; Masmouhi BE; Ndour CT; Huguet-Jacquot S; Mailloux A; Cortey A; Jouannic JM; Maisonneuve E
    Transfusion; 2021 Jun; 61(6):1972-1979. PubMed ID: 33811650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Example of a woman with multiple intrauterine deaths due to anti-M who delivered a live child after plasmapheresis.
    Furukawa K; Nakajima T; Kogure T; Yazaki K; Yoshida M; Fukaishi T; Ibuki Y; Igarashi M
    Exp Clin Immunogenet; 1993; 10(3):161-7. PubMed ID: 8286126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of a P-incompatible pregnancy using double filtration plasmapheresis.
    Taniguchi F; Horie S; Tsukihara S; Nagata N; Nishikawa K; Terakawa N
    Gynecol Obstet Invest; 2003; 56(2):117-20. PubMed ID: 12939562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 15. A Canadian Christmas.
    Sherrington AM
    Can Med Assoc J; 1980 Dec; 123(11):1089. PubMed ID: 6780178
    [No Abstract]   [Full Text] [Related]  

  • 16. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rh-D isoimmunization.
    Body JJ; Strickler RC; McClure PD; Freedman MH
    Can Med Assoc J; 1972 Aug; 107(4):275-6. PubMed ID: 4626766
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of severe rhesus D-incompatible pregnancy with repeated double-filtration plasmapheresis.
    Kamei K; Yamaguchi K; Sato M; Ogura M; Ito S; Okada T; Wada S; Sago H
    J Clin Apher; 2015 Oct; 30(5):305-7. PubMed ID: 25413689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemostaseologic studies of maternal blood in intrauterine retardation and threatened premature labor].
    Voigt T; Voigt H
    Zentralbl Gynakol; 1985; 107(6):370-80. PubMed ID: 4002923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.